The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
